News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
The ASCO Post – Immunoglobulin G Testing May Reduce Infections in CLL and NHL
Jun 27, 2024, 19:31

The ASCO Post – Immunoglobulin G Testing May Reduce Infections in CLL and NHL

The ASCO Post shared on X:

“Immunoglobulin G Testing May Reduce Infections, Increase Receipt of Immunoglobulin Replacement Therapy in Patients With CLL and NHL.”.

Read further.
Source: The ASCO Post/X

cancer Immunoglobulin G OncoDaily Oncology The ASCO Post
Blog
Jul 2, 2024, 04:32
Zhe Huang: Thrilled to be selected for Best Poster for prostate cancer at PrevConf24
Insight
Jul 2, 2024, 04:16
Olivier Calvayrac: TT-derived drug-tolerant (DT) lung cancer cells are vulnerable to FTIs
Blog
Jul 2, 2024, 03:57
Runcie C.W. Chidebe: Tangible progress hinges on addressing the realities faced by LMICs
Blog
Jul 2, 2024, 03:16
C. Jillian Tsai: A very thoughtful opinion piece on caveats of using TTMV-HPV DNA in oropharyngeal carcinoma
Blog
Jul 2, 2024, 03:02
Myriam Chalabi: Patients with stage 1c TNBC with high TILs have an excellent prognosis without chemo
Blog
Jul 2, 2024, 02:23
Dinesh Pendharkar receives Times Now Inspiring Oncologist of India Recognition
Blog
Jul 2, 2024, 02:13
Buvanes Tharmalingam: Recognition for Patient Group Capability Building Initiatives 
Blog
Jul 2, 2024, 02:01
Sergio Cifuentes Canaval: Exciting Advances in Immunotherapy for Colon Cancer
Blog
Jul 2, 2024, 02:01
SCION 2025 equips participants with insights into cancer immunotherapy clinical trials - SITC
Career
Jul 2, 2024, 01:43
Christian Rolfo joins James Cancer Hospital & Solove Research Institute team as director of our Division of Medical Oncology
Blog
Jul 2, 2024, 01:33
National Cancer Institute - Warren Kibbe is the new deputy director for data science and strategy
Insight
Jul 1, 2024, 23:51
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma